Vertex Pharmaceuticals Incorporated (VX1.DE)
EUR 430.2
(-1.19%)
EUR 430.2
(-1.19%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 13.89 USD | 9.94% |
| 2022 | 12.78 USD | 40.59% |
| 2021 | 9.09 USD | -12.93% |
| 2020 | 10.44 USD | 127.95% |
| 2019 | 4.58 USD | -44.48% |
| 2018 | 8.25 USD | 678.3% |
| 2017 | 1.06 USD | 330.43% |
| 2016 | -0.46 USD | 80.09% |
| 2015 | -2.31 USD | 26.43% |
| 2014 | -3.14 USD | -58.59% |
| 2013 | -1.98 USD | -296.0% |
| 2012 | -0.50 USD | -457.14% |
| 2011 | 0.14 USD | 103.71% |
| 2010 | -3.77 USD | -1.89% |
| 2009 | -3.70 USD | -13.15% |
| 2008 | -3.27 USD | -7.92% |
| 2007 | -3.03 USD | -65.57% |
| 2006 | -1.83 USD | 19.74% |
| 2005 | -2.28 USD | -7.55% |
| 2004 | -2.12 USD | 17.19% |
| 2003 | -2.56 USD | -79.02% |
| 2002 | -1.43 USD | -60.67% |
| 2001 | -0.89 USD | -50.85% |
| 2000 | -0.59 USD | 26.25% |
| 1999 | -0.80 USD | -23.08% |
| 1998 | -0.65 USD | -58.54% |
| 1997 | -0.41 USD | 61.68% |
| 1996 | -1.07 USD | -69.84% |
| 1995 | -0.63 USD | -12.5% |
| 1994 | -0.56 USD | -800.0% |
| 1993 | 0.08 USD | 122.86% |
| 1992 | -0.35 USD | 0.0% |
| 1991 | -0.35 USD | -6.06% |
| 1990 | -0.33 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -13.92 USD | -426.76% |
| 2024 Q1 | 4.26 USD | 13.3% |
| 2023 Q4 | 3.76 USD | -6.23% |
| 2023 Q2 | 3.55 USD | 30.51% |
| 2023 Q1 | 2.72 USD | -14.73% |
| 2023 FY | - USD | 9.94% |
| 2023 Q3 | 4.01 USD | 12.96% |
| 2022 Q4 | 3.19 USD | -12.12% |
| 2022 FY | - USD | 40.59% |
| 2022 Q1 | 2.99 USD | -0.99% |
| 2022 Q2 | 3.17 USD | 6.02% |
| 2022 Q3 | 3.63 USD | 14.51% |
| 2021 Q4 | 3.02 USD | -8.48% |
| 2021 Q1 | 2.52 USD | 8.62% |
| 2021 Q2 | 0.26 USD | -89.68% |
| 2021 FY | - USD | -12.93% |
| 2021 Q3 | 3.30 USD | 1169.23% |
| 2020 Q4 | 2.32 USD | -9.38% |
| 2020 Q2 | 3.22 USD | 38.79% |
| 2020 Q3 | 2.56 USD | -20.5% |
| 2020 FY | - USD | 127.95% |
| 2020 Q1 | 2.32 USD | 2.65% |
| 2019 FY | - USD | -44.48% |
| 2019 Q2 | 1.04 USD | -0.95% |
| 2019 Q3 | 0.22 USD | -78.85% |
| 2019 Q4 | 2.26 USD | 927.27% |
| 2019 Q1 | 1.05 USD | -82.73% |
| 2018 Q3 | 0.51 USD | -37.8% |
| 2018 Q2 | 0.82 USD | -1.2% |
| 2018 Q1 | 0.83 USD | 107.5% |
| 2018 Q4 | 6.08 USD | 1092.16% |
| 2018 FY | - USD | 678.3% |
| 2017 Q2 | 0.07 USD | -93.07% |
| 2017 Q1 | 1.01 USD | 676.92% |
| 2017 FY | - USD | 330.43% |
| 2017 Q4 | 0.40 USD | 197.56% |
| 2017 Q3 | -0.41 USD | -685.71% |
| 2016 Q4 | 0.13 USD | 176.47% |
| 2016 Q1 | -0.17 USD | 45.16% |
| 2016 Q2 | -0.26 USD | -52.94% |
| 2016 FY | - USD | 80.09% |
| 2016 Q3 | -0.17 USD | 34.62% |
| 2015 Q4 | -0.31 USD | 20.51% |
| 2015 Q1 | -0.83 USD | -12.16% |
| 2015 FY | - USD | 26.43% |
| 2015 Q2 | -0.78 USD | 6.02% |
| 2015 Q3 | -0.39 USD | 50.0% |
| 2014 Q4 | -0.74 USD | -2.78% |
| 2014 FY | - USD | -58.59% |
| 2014 Q2 | -0.68 USD | 32.0% |
| 2014 Q3 | -0.72 USD | -5.88% |
| 2014 Q1 | -1.00 USD | -626.32% |
| 2013 Q2 | -0.26 USD | 81.82% |
| 2013 FY | - USD | -296.0% |
| 2013 Q3 | -0.54 USD | -107.69% |
| 2013 Q4 | 0.19 USD | 135.19% |
| 2013 Q1 | -1.43 USD | -308.57% |
| 2012 Q3 | -0.27 USD | 12.9% |
| 2012 Q1 | 0.44 USD | -27.87% |
| 2012 Q2 | -0.31 USD | -170.45% |
| 2012 Q4 | -0.35 USD | -29.63% |
| 2012 FY | - USD | -457.14% |
| 2011 Q4 | 0.61 USD | -42.45% |
| 2011 Q1 | -0.87 USD | -26.09% |
| 2011 Q3 | 1.06 USD | 224.71% |
| 2011 Q2 | -0.85 USD | 2.3% |
| 2011 FY | - USD | 103.71% |
| 2010 Q4 | -0.69 USD | 33.65% |
| 2010 FY | - USD | -1.89% |
| 2010 Q3 | -1.04 USD | -4.0% |
| 2010 Q2 | -1.00 USD | -20.48% |
| 2010 Q1 | -0.83 USD | -36.07% |
| 2009 Q1 | -1.04 USD | -2.97% |
| 2009 Q4 | -0.61 USD | 27.38% |
| 2009 Q2 | -0.99 USD | 4.81% |
| 2009 FY | - USD | -13.15% |
| 2009 Q3 | -0.84 USD | 15.15% |
| 2008 Q2 | -0.66 USD | 8.33% |
| 2008 FY | - USD | -7.92% |
| 2008 Q3 | -0.93 USD | -40.91% |
| 2008 Q4 | -1.01 USD | -8.6% |
| 2008 Q1 | -0.72 USD | -9.09% |
| 2007 Q1 | -0.64 USD | -166.67% |
| 2007 Q4 | -0.66 USD | 19.51% |
| 2007 Q3 | -0.82 USD | 9.89% |
| 2007 FY | - USD | -65.57% |
| 2007 Q2 | -0.91 USD | -42.19% |
| 2006 FY | - USD | 19.74% |
| 2006 Q3 | -0.46 USD | 36.11% |
| 2006 Q1 | -0.47 USD | -9.3% |
| 2006 Q2 | -0.72 USD | -53.19% |
| 2006 Q4 | -0.24 USD | 47.83% |
| 2005 Q3 | -0.84 USD | -68.0% |
| 2005 Q4 | -0.43 USD | 48.81% |
| 2005 Q2 | -0.50 USD | 10.71% |
| 2005 Q1 | -0.56 USD | -3.7% |
| 2005 FY | - USD | -7.55% |
| 2004 FY | - USD | 17.19% |
| 2004 Q1 | -0.52 USD | 1.89% |
| 2004 Q2 | -0.56 USD | -7.69% |
| 2004 Q3 | -0.49 USD | 12.5% |
| 2004 Q4 | -0.54 USD | -10.2% |
| 2003 FY | - USD | -79.02% |
| 2003 Q1 | 0.27 USD | 164.29% |
| 2003 Q2 | -0.60 USD | -322.22% |
| 2003 Q3 | -1.12 USD | -86.67% |
| 2003 Q4 | -0.53 USD | 52.68% |
| 2002 Q4 | -0.42 USD | 4.55% |
| 2002 Q3 | -0.44 USD | -57.14% |
| 2002 Q1 | -0.29 USD | -562.1% |
| 2002 FY | - USD | -60.67% |
| 2002 Q2 | -0.28 USD | 3.45% |
| 2001 Q2 | -0.20 USD | -33.33% |
| 2001 Q4 | -0.04 USD | 93.05% |
| 2001 FY | - USD | -50.85% |
| 2001 Q1 | -0.15 USD | 28.57% |
| 2001 Q3 | -0.63 USD | -215.0% |
| 2000 FY | - USD | 26.25% |
| 2000 Q4 | -0.21 USD | 54.35% |
| 2000 Q3 | -0.46 USD | -291.67% |
| 2000 Q2 | 0.24 USD | 177.42% |
| 2000 Q1 | -0.31 USD | -1030.93% |
| 1999 Q4 | 0.03 USD | 111.89% |
| 1999 Q2 | -0.21 USD | 40.0% |
| 1999 FY | - USD | -23.08% |
| 1999 Q1 | -0.35 USD | -40.0% |
| 1999 Q3 | -0.28 USD | -33.33% |
| 1998 FY | - USD | -58.54% |
| 1998 Q4 | -0.25 USD | -400.0% |
| 1998 Q3 | -0.05 USD | 75.0% |
| 1998 Q2 | -0.20 USD | -17.65% |
| 1998 Q1 | -0.17 USD | -21.43% |
| 1997 FY | - USD | 61.68% |
| 1997 Q4 | -0.14 USD | -16.67% |
| 1997 Q3 | -0.12 USD | -300.0% |
| 1997 Q2 | -0.03 USD | 76.92% |
| 1997 Q1 | -0.13 USD | -30.0% |
| 1996 FY | - USD | -69.84% |
| 1996 Q4 | -0.10 USD | 41.18% |
| 1996 Q3 | -0.17 USD | 73.44% |
| 1996 Q2 | -0.64 USD | -190.91% |
| 1996 Q1 | -0.22 USD | -809.09% |
| 1995 Q1 | -0.14 USD | 12.5% |
| 1995 FY | - USD | -12.5% |
| 1995 Q4 | -0.02 USD | 87.9% |
| 1995 Q3 | -0.20 USD | 23.08% |
| 1995 Q2 | -0.26 USD | -85.71% |
| 1994 FY | - USD | -800.0% |
| 1994 Q2 | -0.18 USD | -63.64% |
| 1994 Q3 | -0.12 USD | 33.33% |
| 1994 Q4 | -0.16 USD | -33.33% |
| 1994 Q1 | -0.11 USD | -429.34% |
| 1993 Q4 | 0.03 USD | 130.36% |
| 1993 FY | - USD | 122.86% |
| 1993 Q1 | -0.14 USD | -27.27% |
| 1993 Q2 | -0.03 USD | 78.57% |
| 1993 Q3 | -0.11 USD | -266.67% |
| 1992 Q4 | -0.11 USD | -22.22% |
| 1992 FY | - USD | 0.0% |
| 1992 Q3 | -0.09 USD | -12.5% |
| 1992 Q1 | -0.07 USD | -1300.0% |
| 1992 Q2 | -0.08 USD | -14.29% |
| 1991 Q1 | -0.09 USD | 0.0% |
| 1991 Q2 | -0.07 USD | 20.89% |
| 1991 Q4 | -0.01 USD | 92.86% |
| 1991 Q3 | -0.07 USD | 1.69% |
| 1991 FY | - USD | -6.06% |
| 1990 FY | - USD | 0.0% |
| 1990 Q3 | -0.08 USD | 0.0% |
| 1990 Q2 | -0.08 USD | 0.0% |
| 1990 Q1 | -0.08 USD | 0.0% |
| 1990 Q4 | -0.09 USD | -12.5% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioNTech SE | 3.87 EUR | -258.915% |
| CureVac N.V. | -1.18 EUR | 1277.119% |
| Biotest Aktiengesellschaft | 3.21 EUR | -332.71% |
| Biotest Aktiengesellschaft | 3.21 EUR | -332.71% |
| BRAIN Biotech AG | -0.38 EUR | 3755.263% |
| Formycon AG | 4.76 EUR | -191.807% |
| Heidelberg Pharma AG | -0.44 EUR | 3256.818% |
| Medigene AG | -0.66 EUR | 2204.545% |